Screener / SEC EDGAR /CIK 0001516513 /10-K filed May 19, 2026, compared with May 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Technology · IT Services

Doximity, Inc. DOCS

Compare with peers Embed
Earnings releases

Latest results release: Nov 5, 2026

8-K item 2.02, exhibit 99

What DOCS's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

What the company says its adjusted numbers leave out:

• Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non- GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of acquisition and other related expenses, stock-based compensation expense, amortization of acquired intangible assets, legal fees associated with certain non-ordinary course legal matters including the shareholder class action litigation, and change in fair value of contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. release Nov 5, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 5, 2026 · EX-99.1

Doximity Announces Fiscal 2027 Second Quarter Financial Results

Open on SEC

-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2027 second quarter ended September 30, 2026. “We delivered another quarter of record engagement while investing heavily in AI and maintaining a 51% adjusted EBITDA margin,” said Jeff Tangney, co-founder and CEO of Doximity. “More than 190 health systems have now purchased our AI suite, and with UpToDate and DoseCheck, we’re extending our lead in distribution and trust.”

All comparisons, unless otherwise noted, are to the three months ended September 30, 2025.

• Revenue: Revenue of $174.5 million, versus $168.5 million, an increase of 4% year-over-year.

• Net income and non-GAAP net income: Net income of $34.7 million, versus $62.1 million, representing a margin of 19.9%, versus 36.8%. Non-GAAP net income of $68.3 million, versus $90.0 million, representing a margin of 39.1%, versus 53.4%.

• Adjusted EBITDA: Adjusted EBITDA of $88.9 million, versus $100.8 million, a decrease of 12% year-over-year, representing adjusted EBITDA margins of 50.9%, versus 59.8%.

• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.18, versus $0.31, while non-GAAP diluted net income per share was $0.36, versus $0.45.

: Operating cash flow of $93.3 million, versus $93.9 million, a decrease of 1% year-over-year, and free cash flow of $91.3 million, versus $91.6 million, a decrease of less than 1% year-over-year.

Doximity is providing guidance for its fiscal third quarter ending December 31, 2026 as follows:

Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:

For more detailed financial commentary, please refer to the “Modeling Considerations” appendix in our prepared remarks. 1

Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The recorded webcast will be available on the Company’s Investor Relations page shortly after the call.

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 85% of U.S. physicians. With AI-powered clinical reference and search capabilities, Doximity helps doctors access trusted, peer-reviewed information and medical literature. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Forward-looking statements are all statements other than statements of historical fact, and specifically include statements regarding guidance and future business and financial results. These statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including, without limitation, those set forth in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

September 30, 2026 March 31, 2026 ────────────────────────────────────────────────────────────────────────────── Assets Current assets: Cash and cash equivalents $ 218,614 $ 219,178 Marketable securities 494,615 529,423 Accounts receivable, net 166,113 144,783 Prepaid expenses and other current 42,200 50,880 assets Total current assets 921,542 944,264 Property and equipment, net 19,827 18,080 Deferred income tax assets 26,070 31,984 Operating lease right-of-use 6,362 7,140 assets Intangible assets, net 31,444 35,325 Goodwill 84,973 84,973 Other assets 1,552 1,921 Total assets $ 1,091,770 $ 1,123,687 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 6,304 $ 4,009 Accrued expenses and other current 35,865 42,804 liabilities Deferred revenue, current 100,227 106,050 Operating lease liabilities, 2,198 2,110 current Total current liabilities 144,594 154,973 Deferred revenue, non-current 37 400 Operating lease liabilities, 6,948 8,075 non-current Other liabilities, non-current 11,707 9,402 Total liabilities 163,286 172,850 Stockholders' Equity Preferred stock — — Common stock 178 183 Additional paid-in capital 1,068,702 1,001,688 Accumulated other comprehensive income -1,653 28 (loss) Accumulated deficit -138,743 -51,062 Total stockholders’ equity 928,484 950,837 Total liabilities and stockholders’ $ 1,091,770 $ 1,123,687 equity

(1) Costs and expenses include stock-based compensation expense as follows (in thousands):

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

• Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non- GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of acquisition and other related expenses, stock-based compensation expense, amortization of acquired intangible assets, legal fees associated with certain non-ordinary course legal matters including the shareholder class action litigation, and change in fair value of contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.

Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, legal fees associated with certain non-ordinary course legal matters including the shareholder class action litigation, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.

• Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment, purchases of intangible assets, and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results. 6

Net revenue retention rate: Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.

Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business and the value we create for large customers, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin- offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.

• Quarterly unique active providers using our workflow tools: Quarterly unique active providers 1 using our Workflow Tools is a measure of our platform’s usage and adoption among healthcare providers on our platform. We calculate the number of unique active providers by counting providers who securely log in and use any of the following workflow functions on our technology platform during the quarter: placing phone calls or video calls lasting more than 10 seconds, sending voicemails, or sending secure text messages using our Dialer communications tools; sending or receiving faxes; submitting a prompt on Ask (formerly DoxGPT), our HIPAA‑compliant generative AI clinical research tool and writing assistant; conducting research on prescription drugs; reviewing AI responses for our PeerCheck feature; scheduling via our on-call scheduling tool, Amion; or using our HIPAA-compliant ambient note taking tool, Scribe, for a patient visit. Each provider is counted once per quarter, even if they use multiple tools or use them many times.

1 Providers are health care professionals with clinical / prescribing roles, specifically Physicians (MD/DO), Nurse practitioners (NPs), Certified registered nurse anesthetists (CRNAs), Physician assistants (PAs), Pharmacists, and Medical students. 7

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

(1) For the three and six months ended September 30, 2026 and 2025, management used an estimated annual effective non-GAAP tax rate of 21.0%. 10

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
        Doximity Announces Fiscal 2027 Second Quarter Financial Results         
                                                                                
             Total revenues of $174.5 million, up 4% year-over-year             
                                                                                
                   Net income of $34.7 million, margin of 20%                   
                                                                                
                Adjusted EBITDA of $88.9 million, margin of 51%                 
                                                                                
  SAN FRANCISCO, Calif., November 5, 2026                                       
                                                                                
-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical
professionals, today announced results of its fiscal 2027 second quarter ended
September 30, 2026.
“We delivered another quarter of record engagement while investing heavily in AI
and maintaining a 51% adjusted EBITDA margin,” said Jeff Tangney, co-founder and
CEO of Doximity. “More than 190 health systems have now purchased our AI suite,
and with UpToDate and DoseCheck, we’re extending our lead in distribution and
trust.”
                                                                                
   Fiscal 2027 Second Quarter Financial Highlights                              
                                                                                
All comparisons, unless otherwise noted, are to the three months ended September
30, 2025.

• Revenue: Revenue of $174.5 million, versus $168.5 million, an increase of 4%
year-over-year.

• Net income and non-GAAP net income: Net income of $34.7 million, versus $62.1
million, representing a margin of 19.9%, versus 36.8%. Non-GAAP net income of
$68.3 million, versus $90.0 million, representing a margin of 39.1%, versus
53.4%.

• Adjusted EBITDA: Adjusted EBITDA of $88.9 million, versus $100.8 million, a
decrease of 12% year-over-year, representing adjusted EBITDA margins of 50.9%,
versus 59.8%.

• Diluted net income per share and non-GAAP diluted net income per share:
Diluted net income per share was $0.18, versus $0.31, while non-GAAP diluted net
income per share was $0.36, versus $0.45.

•
                                                                                
  Operating cash flow and free cash flow                                        
                                                                                
: Operating cash flow of $93.3 million, versus $93.9 million, a decrease of 1%
year-over-year, and free cash flow of $91.3 million, versus $91.6 million, a
decrease of less than 1% year-over-year.
                                                                                
   Financial Outlook                                                            
                                                                                
Doximity is providing guidance for its fiscal third quarter ending December 31,
2026 as follows:

• Revenue between $195 million and $196 million.

• Adjusted EBITDA between $102.5 million and $103.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2027 as
follows:

• Revenue between $678 million and $683 million.

• Adjusted EBITDA between $317 million and $325 million.

For more detailed financial commentary, please refer to the “Modeling
Considerations” appendix in our prepared remarks.
                                       1                                        
                                                                                
  Conference Call Information                                                   
                                                                                
Doximity posted prepared remarks on its investor relations website at
https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m.
Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To
listen to a live audio webcast, please visit the Company’s Investor Relations
page at https://investors.doximity.com. The recorded webcast will be available
on the Company’s Investor Relations page shortly after the call.
                                                                                
  About Doximity                                                                
                                                                                
Founded in 2010, Doximity is the leading digital platform for U.S. medical
professionals. The company's network members include more than 85% of U.S.
physicians. With AI-powered clinical reference and search capabilities, Doximity
helps doctors access trusted, peer-reviewed information and medical literature.
Doximity's mission is to help doctors be more productive so they can provide
better care for their patients.
                                                                                
  Forward-Looking Statements                                                    
                                                                                
This press release includes forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of the Securities Exchange
Act. Forward-looking statements are all statements other than statements of
historical fact, and specifically include statements regarding guidance and
future business and financial results. These statements reflect our current
views about our plans, intentions, expectations, strategies and prospects, which
are based on the information currently available to us and on assumptions we
have made. Although we believe that our plans, intentions, expectations,
strategies and prospects as reflected in or suggested by those forward-looking
statements are reasonable, we can give no assurance that the plans, intentions,
expectations, or strategies will be attained or achieved. Furthermore, actual
results may differ materially from those described in the forward-looking
statements and will be affected by a variety of risks and factors including,
without limitation, those set forth in the section entitled “Risk Factors” in
our Annual Report on Form 10-K for the fiscal year ended March 31, 2026 and as
may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we
operate in a very competitive and rapidly changing environment. New risks and
uncertainties emerge from time to time, and it is not possible for us to predict
all risks and uncertainties that could cause actual results to differ materially
from those contained in our forward-looking statements. The forward-looking
statements made in this press release relate only to management’s beliefs and
assumptions as of this date. We assume no obligation to update publicly any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by law.

Investor Relations Contact:

Perry Gold

[email protected]

Media Contact:

Richard George

[email protected]
                                       2                                        
                                                                                
                                 DOXIMITY, INC.                                 
                                                                                
                                                                                
                     CONDENSED CONSOLIDATED BALANCE SHEETS                      
                                                                                
                                 (in thousands)                                 
                                                                                
                                  (unaudited)                                   
                                                                                
                                       September 30, 2026       March 31, 2026  
 ────────────────────────────────────────────────────────────────────────────── 
  Assets                                                                        
  Current assets:                                                               
  Cash and cash equivalents         $             218,614    $         219,178  
  Marketable securities                           494,615              529,423  
  Accounts receivable, net                        166,113              144,783  
  Prepaid expenses and other                                                    
  current                                          42,200               50,880  
  assets                                                                        
  Total current assets                            921,542              944,264  
  Property and equipment, net                      19,827               18,080  
  Deferred income tax assets                       26,070               31,984  
  Operating lease right-of-use                      6,362                7,140  
  assets                                                                        
  Intangible assets, net                           31,444               35,325  
  Goodwill                                         84,973               84,973  
  Other assets                                      1,552                1,921  
  Total assets                      $           1,091,770    $       1,123,687  
  Liabilities and Stockholders’                                                 
  Equity                                                                        
  Current liabilities:                                                          
  Accounts payable                  $               6,304    $           4,009  
  Accrued expenses and other                                                    
  current                                          35,865               42,804  
  liabilities                                                                   
  Deferred revenue, current                       100,227              106,050  
  Operating lease liabilities,                      2,198                2,110  
  current                                                                       
  Total current liabilities                       144,594              154,973  
  Deferred revenue, non-current                        37                  400  
  Operating lease liabilities,                      6,948                8,075  
  non-current                                                                   
  Other liabilities, non-current                   11,707                9,402  
  Total liabilities                               163,286              172,850  
  Stockholders' Equity                                                          
  Preferred stock                                       —                    —  
  Common stock                                        178                  183  
  Additional paid-in capital                    1,068,702            1,001,688  
  Accumulated other                                                             
  comprehensive income                             -1,653                   28  
  (loss)                                                                        
  Accumulated deficit                            -138,743              -51,062  
  Total stockholders’ equity                      928,484              950,837  
  Total liabilities and                                                         
  stockholders’                     $           1,091,770    $       1,123,687  
  equity                                                                        
                                                                                
                                       3                                        
                                                                                
                                 DOXIMITY, INC.                                 
                                                                                
                                                                                
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS                 
                                                                                
                     (in thousands, except per share data)                      
                                                                                
                                  (unaudited)                                   
                                                                                
                      Three                               Six                   
                     Months                            Months                   
                      Ended                             Ended                   
                   Septemb…                           Septem…                   
             2026       30,    2025             2026      30,    2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Revenue    $      174,537    $     168,525    $     331,155    $     314,438  
  Cost of            25,346           16,425           49,038           32,218  
  revenu…                                                                       
  Gross             149,191          152,100          282,117          282,220  
  profit                                                                        
  Operat…                                                                       
  expens…                                                                       
  Resear…                                                                       
  and                41,961           30,202           80,439           57,001  
  develo…                                                                       
  Sales                                                                         
  and                46,892           39,168           91,941           75,533  
  market…                                                                       
  General                                                                       
  and                16,416           19,049           32,172           31,488  
  admini…                                                                       
  Total                                                                         
  operat…           105,269           88,419          204,552          164,022  
  expens…                                                                       
  Income                                                                        
  from               43,922           63,681           77,565          118,198  
  operat…                                                                       
  Other                                                                         
  income,             6,405            9,258           13,124           18,888  
  net                                                                           
  Income                                                                        
  before             50,327           72,939           90,689          137,086  
  income                                                                        
  taxes                                                                         
  Provis…                                                                       
  for                15,597           10,880           31,645           21,707  
  income                                                                        
  taxes                                                                         
  Net        $       34,730    $      62,059    $      59,044    $     115,379  
  income                                                                        
  Net                                                                           
  income                                                                        
  per                                                                           
  share                                                                         
  attrib…                                                                       
  to                                                                            
  Class A                                                                       
  and                                                                           
  Class B                                                                       
  common                                                                        
  stockh…                                                                       
  Basic      $         0.19    $        0.33    $        0.33    $        0.61  
  Diluted    $         0.18    $        0.31    $        0.31    $        0.57  
  Weight…                                                                       
  shares                                                                        
  used in                                                                       
  comput…                                                                       
  net                                                                           
  income                                                                        
  per                                                                           
  share                                                                         
  attrib…                                                                       
  to                                                                            
  Class A                                                                       
  and                                                                           
  Class B                                                                       
  common                                                                        
  stockh…                                                                       
  Basic             178,674          187,705          180,611          187,844  
  Diluted           187,804          200,745          189,475          200,952  
                                                                                
(1) Costs and expenses include stock-based compensation expense as follows (in
thousands):
                                                                                
                      Three                                Six                  
                     Months                             Months                  
                      Ended                              Ended                  
                   Septemb…                          September                  
             2026       30,    2025            2026        30,    2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Cost of    $        3,036    $      2,844    $         6,228    $      5,824  
  revenue                                                                       
  Resear…                                                                       
  and                16,028           9,862             31,587          16,511  
  develo…                                                                       
  Sales                                                                         
  and                12,696          10,508             25,121          18,218  
  market…                                                                       
  General                                                                       
  and                 8,805           6,260             14,381          10,786  
  admini…                                                                       
  Total                                                                         
  stock-…    $       40,565    $     29,474    $        77,317    $     51,339  
  compen…                                                                       
  expense                                                                       
                                                                                
                                       4                                        
                                                                                
                                 DOXIMITY, INC.                                 
                                                                                
                                                                                
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                 
                                                                                
                                 (in thousands)                                 
                                                                                
                                  (unaudited)                                   
                                                                                
           Three                              Six                               
  Cash     Months                             Months                            
  flows    Ended                              Ended                             
  from     Septe…                             Septem…                           
  oper…    30,                                30,                               
  acti…    2026               2025            2026               2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Net      $        34,730    $     62,059    $        59,044    $     115,379  
  inco…                                                                         
  Adju…                                                                         
  to                                                                            
  reco…                                                                         
  net                                                                           
  inco…                                                                         
  to                                                                            
  net                                                                           
  cash                                                                          
  prov…                                                                         
  by                                                                            
  oper…                                                                         
  acti…                                                                         
  Depr…                                                                         
  and                4,353           3,469              8,640            6,263  
  amor…                                                                         
  Stoc…                                                                         
  comp…                                                                         
  net               40,565          29,474             77,317           51,339  
  of                                                                            
  amou…                                                                         
  capi…                                                                         
  Non-…                                                                         
  lease                391             454                778              904  
  expe…                                                                         
  Accr…                                                                         
  of                                                                            
  disc…                                                                         
  on                  -358          -2,199               -925           -4,687  
  mark…                                                                         
  secu…                                                                         
  net                                                                           
  Amor…                                                                         
  of                                                                            
  defe…              3,858           2,876              8,158            6,772  
  cont…                                                                         
  costs                                                                         
  Other                358             294                 20             -114  
  Chan…                                                                         
  in                                                                            
  oper…                                                                         
  asse…                                                                         
  and                                                                           
  liab…                                                                         
  Acco…             11,366          12,396             -21,9…             -985  
  rece…                                                                         
  Prep…                                                                         
  expe…                                                                         
  and                5,259           7,685             14,384            3,451  
  other                                                                         
  asse…                                                                         
  Defe…                                                                         
  cont…             -2,577          -2,584             -5,219           -4,549  
  costs                                                                         
  Acco…                                                                         
  paya…                                                                         
  accr…                                                                         
  expe…              4,701          -2,168              2,268           -2,333  
  and                                                                           
  other                                                                         
  liab…                                                                         
  Defe…             -8,834          -17,2…             -6,186          -14,268  
  reve…                                                                         
  Oper…                                                                         
  lease               -527            -571             -1,039           -1,127  
  liab…                                                                         
  Net                                                                           
  cash                                                                          
  prov…             93,285          93,944             135,2…          156,045  
  by                                                                            
  oper…                                                                         
  acti…                                                                         
  Cash                                                                          
  flows                                                                         
  from                                                                          
  inve…                                                                         
  acti…                                                                         
  Cash                                                                          
  paid                                                                          
  for                                                                           
  acqu…                  —          -26,5…                  —          -26,528  
  net                                                                           
  of                                                                            
  cash                                                                          
  acqu…                                                                         
  Purc…                                                                         
  of                                                                            
  prop…                  —               —                -62                —  
  and                                                                           
  equi…                                                                         
  Inte…                                                                         
  soft…             -1,953          -2,369             -4,275           -4,335  
  deve…                                                                         
  costs                                                                         
  Purc…                                                                         
  of               -168,4…          -128,…             -183,…          -268,2…  
  mark…                                                                         
  secu…                                                                         
  Matu…                                                                         
  of                86,396          125,4…             212,4…          270,031  
  mark…                                                                         
  secu…                                                                         
  Sales                                                                         
  of                     —               —              4,049                —  
  mark…                                                                         
  secu…                                                                         
  Net                                                                           
  cash                                                                          
  prov…                                                                         
  by               -84,033          -31,7…             28,957          -29,032  
  (used                                                                         
  in)                                                                           
  inve…                                                                         
  acti…                                                                         
  Cash                                                                          
  flows                                                                         
  from                                                                          
  fina…                                                                         
  acti…                                                                         
  Proc…                                                                         
  from                                                                          
  issu…                                                                         
  of                                                                            
  comm…                                                                         
  stock                                                                         
  upon                                                                          
  exer…                908           2,398              3,988            4,796  
  of                                                                            
  stock                                                                         
  opti…                                                                         
  and                                                                           
  comm…                                                                         
  stock                                                                         
  warr…                                                                         
  Proc…                                                                         
  from                                                                          
  issu…                                                                         
  of                                                                            
  comm…                                                                         
  stock                                                                         
  in                 1,288           1,816              1,288            1,816  
  conn…                                                                         
  with                                                                          
  the                                                                           
  empl…                                                                         
  stock                                                                         
  purc…                                                                         
  plan                                                                          
  Taxes                                                                         
  paid                                                                          
  rela…                                                                         
  to                                                                            
  net               -9,948          -12,5…             -16,9…          -24,493  
  share                                                                         
  sett…                                                                         
  of                                                                            
  equi…                                                                         
  awar…                                                                         
  Repu…                                                                         
  of               -54,198          -21,8…             -145,…          -144,2…  
  comm…                                                                         
  stock                                                                         
  Paym…                                                                         
  of                                                                            
  cont…                                                                         
  cons…                  —               —             -5,024           -5,249  
  rela…                                                                         
  to a                                                                          
  busi…                                                                         
  comb…                                                                         
  Paym…                                                                         
  of                                                                            
  exci…                                                                         
  taxes             -2,292               —             -2,292                —  
  on                                                                            
  share                                                                         
  repu…                                                                         
  Net                                                                           
  cash                                                                          
  used             -64,242          -30,2…             -164,…          -167,3…  
  in                                                                            
  fina…                                                                         
  acti…                                                                         
  Net                                                                           
  incr…                                                                         
  (dec…                                                                         
  in               -54,990          31,988               -564          -40,365  
  cash                                                                          
  and                                                                           
  cash                                                                          
  equi…                                                                         
  Cash                                                                          
  and                                                                           
  cash                                                                          
  equi…            273,604          137,2…             219,1…          209,614  
  begi…                                                                         
  of                                                                            
  peri…                                                                         
  Cash                                                                          
  and                                                                           
  cash                                                                          
  equi…    $       218,614    $     169,2…    $        218,6…    $     169,249  
  end                                                                           
  of                                                                            
  peri…                                                                         
  Supp…                                                                         
  disc…                                                                         
  of                                                                            
  cash                                                                          
  flow                                                                          
  info…                                                                         
  Cash                                                                          
  paid                                                                          
  for                                                                           
  taxe…    $        10,126    $     14,369    $        14,116    $      19,347  
  net                                                                           
  of                                                                            
  refu…                                                                         
                                                                                
                                       5                                        
                                                                                
   Non-GAAP Financial Measures                                                  
                                                                                
To supplement our condensed consolidated financial statements, which are
prepared and presented in accordance with accounting principles generally
accepted in the United States (“GAAP”), the Company uses the following non-GAAP
measures of financial performance:

• Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-
GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net
income per common share: We exclude the effect of acquisition and other related
expenses, stock-based compensation expense, amortization of acquired intangible
assets, legal fees associated with certain non-ordinary course legal matters
including the shareholder class action litigation, and change in fair value of
contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP
gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net
income margin are further adjusted for estimated income tax on such adjustments.
We calculate income taxes on the adjustments by applying an estimated annual
effective tax rate to the adjustments. Non-GAAP basic and diluted net income per
common share is non-GAAP net income attributable to common stockholders divided
by the weighted average number of shares. For both basic and diluted non-GAAP
net income per share, the weighted average shares we use in computing non-GAAP
net income per share is equal to our GAAP weighted average shares. Non-GAAP
gross margin represents non-GAAP gross profit as a percentage of revenue and
non-GAAP net income margin represents non-GAAP net income as a percentage of
revenue.
                                                                                
  •                                                                             
                                                                                
Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net
income before interest, income taxes, depreciation, and amortization, and as
further adjusted for acquisition and other related expenses, stock-based
compensation expense, legal fees associated with certain non-ordinary course
legal matters including the shareholder class action litigation, change in fair
value of contingent earn-out consideration liability, and other income, net. Net
income margin represents net income as a percentage of revenue and adjusted
EBITDA margin represents adjusted EBITDA as a percentage of revenue.

• Free cash flow: We calculate free cash flow as cash flow from operating
activities less purchases of property and equipment, purchases of intangible
assets, and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and
operational decision-making purposes and as a means to evaluate period-to-period
comparisons. Non-GAAP financial measures are not meant to be considered in
isolation or as a substitute for comparable GAAP financial measures and should
be read only in conjunction with our condensed consolidated financial statements
prepared in accordance with GAAP. Our presentation of non-GAAP financial
measures may not be comparable to similar measures used by other companies. We
encourage investors to carefully consider our results under GAAP, as well as our
supplemental non-GAAP information and the reconciliation between these
presentations, to more fully understand our business. Please see the tables
included at the end of this release for the reconciliation of GAAP to non-GAAP
results.
                                       6                                        
                                                                                
   Key Business Metrics                                                         
                                                                                
                                                                                
  •                                                                             
                                                                                
Net revenue retention rate: Our net revenue retention rate compares our
subscription revenue from the same set of customers across comparable periods,
and reflects customer renewals, expansion, contraction, and churn. Net revenue
retention rate is calculated by taking the trailing 12-month (“TTM”)
subscription-based revenue from our customers that had revenue in the prior TTM
period and dividing that by the total subscription-based revenue for the prior
TTM period. For the purposes of this calculation, subscription revenue excludes
subscriptions for individuals and small practices and other non-recurring items.
Our net revenue retention rate is directly tied to our revenue growth rate and
thus fluctuates as that growth rate fluctuates.
                                                                                
  •                                                                             
                                                                                
Customers with trailing 12-month subscription revenue greater than $500,000: The
number of customers with TTM subscription revenue greater than $500,000 is a key
indicator of the scale of our business and the value we create for large
customers, and is calculated by counting the number of customers that
contributed more than $500,000 in subscription revenue in the TTM period. Our
customer count is subject to adjustments for acquisitions, consolidations, spin-
offs, and other market activity, and we present our total customer count for
historical periods reflecting these adjustments.

• Quarterly unique active providers using our workflow tools: Quarterly unique
active providers 1 using our Workflow Tools is a measure of our platform’s usage
and adoption among healthcare providers on our platform. We calculate the number
of unique active providers by counting providers who securely log in and use any
of the following workflow functions on our technology platform during the
quarter: placing phone calls or video calls lasting more than 10 seconds,
sending voicemails, or sending secure text messages using our Dialer
communications tools; sending or receiving faxes; submitting a prompt on Ask
(formerly DoxGPT), our HIPAA‑compliant generative AI clinical research tool and
writing assistant; conducting research on prescription drugs; reviewing AI
responses for our PeerCheck feature; scheduling via our on-call scheduling tool,
Amion; or using our HIPAA-compliant ambient note taking tool, Scribe, for a
patient visit. Each provider is counted once per quarter, even if they use
multiple tools or use them many times.

1 Providers are health care professionals with clinical / prescribing roles,
specifically Physicians (MD/DO), Nurse practitioners (NPs), Certified registered
nurse anesthetists (CRNAs), Physician assistants (PAs), Pharmacists, and Medical
students.
                                       7                                        
                                                                                
   Reconciliation of GAAP to Non-GAAP Financial Measures                        
                                                                                
The following tables reconcile the specific items excluded from GAAP metrics in
the calculation of non-GAAP metrics for the periods shown below:
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                                                                 
          30,                                                                   
          2026                                 Six                              
          (una…                                Mon…                             
          (in                                  End…                             
          thou…                                Sep…                             
          exce…                                30,                              
          perc…              2025              2026              2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Net     $      34,7…       $     62,0…       $     59,0…       $     115…     
  inc…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Acq…                                                                          
  and                                                                           
  oth…               —             1,188                 —             1,6…     
  rel…                                                                          
  exp…                                                                          
  Sto…           40,5…             29,4…             77,3…             51,…     
  com…                                                                          
  Dep…                                                                          
  and            4,353             3,469             8,640             6,2…     
  amo…                                                                          
  Pro…                                                                          
  for            15,5…             10,8…             31,6…             21,…     
  inc…                                                                          
  tax…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                 —                91                90              259     
  con…                                                                          
  ear…                                                                          
  con…                                                                          
  lia…                                                                          
  Leg…              25             2,927                25             2,9…     
  exp…                                                                          
  Oth…                                                                          
  inc…           -6,4…             -9,2…             -13,…             -18…     
  net                                                                           
  Adj…    $      88,8…       $     100,…       $     163,…       $     180…     
  EBI…                                                                          
  Rev…    $      174,…       $     168,…       $     331,…       $     314…     
  Net                                                                           
  inc…              20  %             37  %             18  %            37  %  
  mar…                                                                          
  Adj…                                                                          
  EBI…              51  %             60  %             49  %            57  %  
  mar…                                                                          
                                                                                
                                                                                
           Three                                                                
           Months                                                               
           Ended                                                                
           Septem…                             Six                              
           30,                                 Months                           
           2026                                Ended                            
           (unaud…                             Septe…                           
           (in                                 30,                              
           thousa…            2025             2026               2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  cash                                                                          
  prov…    $        93,285    $      93,944    $       135,272    $     156,0…  
  by                                                                            
  oper…                                                                         
  acti…                                                                         
  Purc…                                                                         
  of                                                                            
  prop…                  —                —                -62               —  
  and                                                                           
  equi…                                                                         
  Inte…                                                                         
  soft…             -1,953           -2,369             -4,275          -4,335  
  deve…                                                                         
  costs                                                                         
  Free                                                                          
  cash     $        91,332    $      91,575    $       130,935    $     151,7…  
  flow                                                                          
  Other                                                                         
  cash                                                                          
  flow                                                                          
  comp…                                                                         
  Net                                                                           
  cash                                                                          
  prov…                                                                         
  by       $        -84,0…    $     -31,711    $        28,957    $     -29,0…  
  (used                                                                         
  in)                                                                           
  inve…                                                                         
  acti…                                                                         
  Net                                                                           
  cash                                                                          
  used     $        -64,2…    $     -30,245    $       -164,7…    $     -167,…  
  in                                                                            
  fina…                                                                         
  acti…                                                                         
                                                                                
                                       8                                        
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                                                                 
          30,                                                                   
          2026                                                                  
          (una…                                                                 
          (in                                                                   
          thou…                                                                 
          exce…                                Six                              
          per                                  Mon…                             
          share                                End…                             
          data                                 Sep…                             
          and                                  30,                              
          perc…              2025              2026              2025           
 ────────────────────────────────────────────────────────────────────────────── 
  GAAP                                                                          
  cost    $      25,3…       $     16,4…       $     49,0…       $     32,…     
  of                                                                            
  rev…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Sto…           -3,0…             -2,8…             -6,2…             -5,…     
  com…                                                                          
  Amo…                                                                          
  of              -935                 —             -1,8…                —     
  acq…                                                                          
  int…                                                                          
  Non…                                                                          
  cost    $      21,3…       $     13,5…       $     40,9…       $     26,…     
  of                                                                            
  rev…                                                                          
  GAAP                                                                          
  gro…    $      149,…       $     152,…       $     282,…       $     282…     
  pro…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Sto…           3,036             2,844             6,228             5,8…     
  com…                                                                          
  Amo…                                                                          
  of               935                 —             1,870                —     
  acq…                                                                          
  int…                                                                          
  Non…                                                                          
  gro…    $      153,…       $     154,…       $     290,…       $     288…     
  pro…                                                                          
  GAAP                                                                          
  gro…            85.5  %           90.3  %           85.2  %          89.8  %  
  mar…                                                                          
  Non…                                                                          
  gro…            87.8  %           91.9  %           87.6  %          91.6  %  
  mar…                                                                          
  GAAP                                                                          
  res…                                                                          
  and     $      41,9…       $     30,2…       $     80,4…       $     57,…     
  dev…                                                                          
  exp…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Sto…           -16,…             -9,8…             -31,…             -16…     
  com…                                                                          
  Amo…                                                                          
  of                 —              -623                 —             -623     
  acq…                                                                          
  int…                                                                          
  Non…                                                                          
  res…                                                                          
  and     $      25,9…       $     19,7…       $     48,8…       $     39,…     
  dev…                                                                          
  exp…                                                                          
  GAAP                                                                          
  sal…                                                                          
  and     $      46,8…       $     39,1…       $     91,9…       $     75,…     
  mar…                                                                          
  exp…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Sto…           -12,…             -10,…             -25,…             -18…     
  com…                                                                          
  Amo…                                                                          
  of             -1,0…             -1,0…             -2,0…             -2,…     
  acq…                                                                          
  int…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                 —               -91               -90             -259     
  con…                                                                          
  ear…                                                                          
  con…                                                                          
  lia…                                                                          
  Non…                                                                          
  sal…                                                                          
  and     $      33,1…       $     27,5…       $     64,7…       $     55,…     
  mar…                                                                          
  exp…                                                                          
  GAAP                                                                          
  gen…                                                                          
  and     $      16,4…       $     19,0…       $     32,1…       $     31,…     
  adm…                                                                          
  exp…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Acq…                                                                          
  and                                                                           
  oth…               —             -1,1…                 —             -1,…     
  rel…                                                                          
  exp…                                                                          
  Sto…           -8,8…             -6,2…             -14,…             -10…     
  com…                                                                          
  Leg…             -25             -2,9…               -25             -2,…     
  exp…                                                                          
  Non…                                                                          
  gen…                                                                          
  and     $      7,586       $     8,674       $     17,7…       $     16,…     
  adm…                                                                          
  exp…                                                                          
  GAAP                                                                          
  ope…    $      105,…       $     88,4…       $     204,…       $     164…     
  exp…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Acq…                                                                          
  and                                                                           
  oth…               —             -1,1…                 —             -1,…     
  rel…                                                                          
  exp…                                                                          
  Sto…           -37,…             -26,…             -71,…             -45…     
  com…                                                                          
  Amo…                                                                          
  of             -1,0…             -1,6…             -2,0…             -2,…     
  acq…                                                                          
  int…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                 —               -91               -90             -259     
  con…                                                                          
  ear…                                                                          
  con…                                                                          
  lia…                                                                          
  Leg…             -25             -2,9…               -25             -2,…     
  exp…                                                                          
  Non…                                                                          
  ope…    $      66,7…       $     55,9…       $     131,…       $     111…     
  exp…                                                                          
                                                                                
                                       9                                        
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                                                                 
          30,                                                                   
          2026                                                                  
          (una…                                                                 
          (in                                                                   
          thou…                                                                 
          exce…                                Six                              
          per                                  Mon…                             
          share                                End…                             
          data                                 Sep…                             
          and                                  30,                              
          perc…              2025              2026              2025           
 ────────────────────────────────────────────────────────────────────────────── 
  GAAP                                                                          
  ope…    $      43,9…       $     63,6…       $     77,5…       $     118…     
  inc…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Acq…                                                                          
  and                                                                           
  oth…               —             1,188                 —             1,6…     
  rel…                                                                          
  exp…                                                                          
  Sto…           40,5…             29,4…             77,3…             51,…     
  com…                                                                          
  Amo…                                                                          
  of             1,940             1,625             3,881             2,6…     
  acq…                                                                          
  int…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                 —                91                90              259     
  con…                                                                          
  ear…                                                                          
  con…                                                                          
  lia…                                                                          
  Leg…              25             2,927                25             2,9…     
  exp…                                                                          
  Non…                                                                          
  ope…    $      86,4…       $     98,9…       $     158,…       $     176…     
  inc…                                                                          
  GAAP                                                                          
  net     $      34,7…       $     62,0…       $     59,0…       $     115…     
  inc…                                                                          
  Adj…                                                                          
  to                                                                            
  exc…                                                                          
  the                                                                           
  fol…                                                                          
  Acq…                                                                          
  and                                                                           
  oth…               —             1,188                 —             1,6…     
  rel…                                                                          
  exp…                                                                          
  Sto…           40,5…             29,4…             77,3…             51,…     
  com…                                                                          
  Amo…                                                                          
  of             1,940             1,625             3,881             2,6…     
  acq…                                                                          
  int…                                                                          
  Cha…                                                                          
  in                                                                            
  fair                                                                          
  val…                                                                          
  of                 —                91                90              259     
  con…                                                                          
  ear…                                                                          
  con…                                                                          
  lia…                                                                          
  Leg…              25             2,927                25             2,9…     
  exp…                                                                          
  Inc…                                                                          
  tax                                                                           
  eff…           -8,9…             -7,4…             -17,…             -12…     
  of                                                                            
  non…                                                                          
  adj…                                                                          
  Non…                                                                          
  net     $      68,3…       $     89,9…       $     123,…       $     161…     
  inc…                                                                          
  Non…                                                                          
  net             39.1  %           53.4  %           37.2  %          51.5  %  
  inc…                                                                          
  mar…                                                                          
  Wei…                                                                          
  sha…                                                                          
  used                                                                          
  in                                                                            
  com…                                                                          
  net                                                                           
  inc…                                                                          
  per                                                                           
  sha…                                                                          
  att…                                                                          
  to                                                                            
  Cla…                                                                          
  A                                                                             
  and                                                                           
  Cla…                                                                          
  B                                                                             
  com…                                                                          
  sto…                                                                          
  Bas…           178,…             187,…             180,…             187…     
  Dil…           187,…             200,…             189,…             200…     
  Non…                                                                          
  net                                                                           
  inc…                                                                          
  per                                                                           
  sha…                                                                          
  att…                                                                          
  to                                                                            
  Cla…                                                                          
  A                                                                             
  and                                                                           
  Cla…                                                                          
  B                                                                             
  sto…                                                                          
  Bas…    $       0.38       $      0.48       $      0.68       $     0.86     
  Dil…    $       0.36       $      0.45       $      0.65       $     0.81     
                                                                                
(1) For the three and six months ended September 30, 2026 and 2025, management
used an estimated annual effective non-GAAP tax rate of 21.0%.
                                       10                                       

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DOCS/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.